Treatment options for managing atherogenic dyslipidemia and fatty liver disease

Author： Rizzo Manfredi   Montalto Giuseppe   Al-Rasadi Khalid  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.8, 2014-06, pp. : 1065-1068

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Current treatment for nonalcoholic fatty liver disease

By Katsiki Niki   Athyros Vasilios G   Karagiannis Asterios   Mikhailidis Dimitri P  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2141-2142

Informa Healthcare

Access to resources Recommend Favorite

Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease

By Harrison S.A.   Bisceglie A.M.D.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2379-2394

Adis International

Access to resources Recommend Favorite

Which Treatment for Nonalcoholic Fatty Liver Disease?

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 8, 2008-07 ,pp. : 767-775

Bentham Science Publishers

Access to resources Recommend Favorite

Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome

By Moscatiello Simona   Di Luzio Raffaella   Sasdelli Anna Simona   Marchesini Giulio  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. : 2657-2672

Informa Healthcare

Access to resources Recommend Favorite

Metformin may have potential for the treatment of fatty liver disease

By  

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite